KBC Group NV increased its stake in shares of Exelon Co. (NASDAQ:EXC - Free Report) by 65.5% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 148,055 shares of the company's stock after acquiring an additional 58,620 shares during the period. KBC Group NV's holdings in Exelon were worth $6,004,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in EXC. Lazard Asset Management LLC grew its holdings in Exelon by 112.4% in the 1st quarter. Lazard Asset Management LLC now owns 31,527,396 shares of the company's stock worth $1,184,483,000 after buying an additional 16,686,526 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its position in Exelon by 2.4% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 4,887,035 shares of the company's stock worth $183,606,000 after acquiring an additional 113,428 shares during the last quarter. CANADA LIFE ASSURANCE Co lifted its holdings in shares of Exelon by 4.6% during the first quarter. CANADA LIFE ASSURANCE Co now owns 4,374,891 shares of the company's stock worth $164,623,000 after buying an additional 193,223 shares during the last quarter. Los Angeles Capital Management LLC grew its position in Exelon by 666.2% in the 2nd quarter. Los Angeles Capital Management LLC now owns 3,583,477 shares of the company's stock worth $124,024,000 after purchasing an additional 3,115,763 shares during the last quarter. Finally, Bank of Montreal Can increased its stake in Exelon by 0.5% during the second quarter. Bank of Montreal Can now owns 3,438,056 shares of the company's stock valued at $120,710,000 after acquiring an additional 15,620 shares during the period. Hedge funds and other institutional investors own 80.92% of the company's stock.
Exelon Price Performance
NASDAQ EXC traded up $0.16 during trading hours on Monday, reaching $39.27. The company's stock had a trading volume of 3,712,756 shares, compared to its average volume of 6,742,671. The firm has a market capitalization of $39.46 billion, a price-to-earnings ratio of 16.09, a P/E/G ratio of 2.79 and a beta of 0.54. The company's 50-day moving average is $39.68 and its two-hundred day moving average is $37.79. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.97. Exelon Co. has a 1-year low of $33.35 and a 1-year high of $41.42.
Exelon (NASDAQ:EXC - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.71 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.04. The company had revenue of $6.15 billion for the quarter, compared to analyst estimates of $5.85 billion. Exelon had a net margin of 10.60% and a return on equity of 9.47%. Exelon's revenue was up 2.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.67 EPS. On average, equities analysts predict that Exelon Co. will post 2.45 EPS for the current year.
Exelon Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Shareholders of record on Monday, November 11th will be paid a dividend of $0.38 per share. This represents a $1.52 annualized dividend and a yield of 3.87%. The ex-dividend date is Friday, November 8th. Exelon's dividend payout ratio (DPR) is presently 62.55%.
Analysts Set New Price Targets
A number of research firms have commented on EXC. Scotiabank boosted their price target on shares of Exelon from $37.00 to $40.00 and gave the company a "sector perform" rating in a research report on Tuesday, August 20th. Jefferies Financial Group assumed coverage on Exelon in a report on Thursday, September 19th. They set a "buy" rating and a $46.00 price target for the company. Morgan Stanley increased their price objective on Exelon from $42.00 to $45.00 and gave the company an "equal weight" rating in a research report on Wednesday, September 25th. Wells Fargo & Company boosted their price target on shares of Exelon from $40.00 to $42.00 and gave the company an "equal weight" rating in a report on Friday, August 2nd. Finally, Barclays boosted their price objective on shares of Exelon from $41.00 to $44.00 and gave the company an "overweight" rating in a research report on Tuesday, October 15th. Eleven equities research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $41.33.
Check Out Our Latest Analysis on Exelon
Exelon Profile
(
Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.